CYCLOSPORINE, FK506, MYCOPHENOLATE MOFETIL, AND PREDNISOLONE DIFFERENTIALLY MODULATE CYTOKINE GENE EXPRESSION IN HUMAN AIRWAY-DERIVED EPITHELIAL CELLS
- 15 April 2000
- journal article
- research article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 69 (7) , 1408-1413
- https://doi.org/10.1097/00007890-200004150-00034
Abstract
Background. The immunosuppressive effects of cyclosporine (CsA), tacrolimus (FK506), mycophenolate mofetil (MMF), and prednisolone in cells from the immunological compartment are well documented. In contrast, limited information is available with respect to the effects of these immunosuppressive drugs on airway-epithelial cells, although these cells may contribute to the development of obliterative bronchiolitis (OB) through the production of interleukin (IL)-6 and IL-8. Methods. We studied the production of IL-6 and IL-8 proteins by airway-derived epithelial cell lines and primary epithelial cell cultures obtained from lung brushings. Transcriptional mechanisms were detected by transient transfections. Results. We demonstrate that CsA dose dependently induces the production of the proinflammatory cytokines IL-6 and IL-8 in both cell lines and primary epithelial cells. FK506 and MMF were also able to up-regulate IL-8, although the effect was less dramatic than observed for CsA. Low concentrations of prednisolone (0.01 and 0.001 μg/ml) enhanced IL-6 and IL-8 secretion, whereas concentrations ≥0.01 μg/ml significantly diminished IL-6 secretion. Furthermore, we showed that CsA and prednisolone mediate their effects at the transcriptional level. Conclusions. The data provide evidence that relevant concentrations of CsA and MMF in vivo may enhance the inflammatory processes in the lower airways of patients after lung transplantation.Keywords
This publication has 25 references indexed in Scilit:
- Cyclosporine induces cancer progression by a cell-autonomous mechanismNature, 1999
- Effect of IL-6 on Alveolar Fibroblast Proliferation in Interstitial Lung DiseasesClinical Immunology and Immunopathology, 1996
- Pharmacokinetics and Bioavailability of Mycophenolate Mofetil in Healthy Subjects after Single‐Dose Oral and Intravenous AdministrationThe Journal of Clinical Pharmacology, 1996
- Molecular mechanism of interleukin-8 gene expressionJournal of Leukocyte Biology, 1994
- Mycophenolate mofetil: Molecular mechanisms of actionPerspectives in Drug Discovery and Design, 1994
- Calcineurin acts in synergy with PMA to inactivate I kappa B/MAD3, an inhibitor of NF-kappa B.The EMBO Journal, 1994
- Anti-inflammatory actions of steroids: molecular mechanismsTrends in Pharmacological Sciences, 1993
- FK-506- and CsA-sensitive activation of the interleukin-2 promoter by calcineurinNature, 1992
- Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexesCell, 1991
- The actions of cyclosporin A and FK506 suggest a novel step in the activation of T lymphocytes.The EMBO Journal, 1990